SETD1A and hepatocellular carcinoma: In summary, we identified the H3K4 methyltransferase SETD1A as an oncogenic regulator driving HCC stemness through epigenetic modification and PABPC1 to promote oncogene transcription, providing an attractive therapeutic target for the treatment of HCC.